- Home
- VRNA vs CAAP Comparison
VRNA vs CAAP Comparison
Compare VRNA & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- CAAP
- Stock Information
- Founded
- VRNA 2005
- CAAP 1998
- Country
- VRNA United Kingdom
- CAAP Luxembourg
- Employees
- VRNA N/A
- CAAP N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- CAAP Aerospace
- Sector
- VRNA Health Care
- CAAP Consumer Discretionary
- Exchange
- VRNA Nasdaq
- CAAP Nasdaq
- Market Cap
- VRNA 3.2B
- CAAP 3.0B
- IPO Year
- VRNA 2017
- CAAP 2018
- Fundamental
- Price
- VRNA $43.06
- CAAP $20.31
- Analyst Decision
- VRNA Strong Buy
- CAAP Strong Buy
- Analyst Count
- VRNA 6
- CAAP 1
- Target Price
- VRNA $43.83
- CAAP $21.50
- AVG Volume (30 Days)
- VRNA 1.0M
- CAAP 210.3K
- Earning Date
- VRNA 11-04-2024
- CAAP 11-20-2024
- Dividend Yield
- VRNA N/A
- CAAP N/A
- EPS Growth
- VRNA N/A
- CAAP 115.99
- EPS
- VRNA N/A
- CAAP 2.09
- Revenue
- VRNA $5,624,000.00
- CAAP $1,496,122,000.00
- Revenue This Year
- VRNA N/A
- CAAP $25.35
- Revenue Next Year
- VRNA $644.06
- CAAP $20.40
- P/E Ratio
- VRNA N/A
- CAAP $9.91
- Revenue Growth
- VRNA 1127.95
- CAAP N/A
- 52 Week Low
- VRNA $11.39
- CAAP $13.74
- 52 Week High
- VRNA $43.73
- CAAP $20.79
- Technical
- Relative Strength Index (RSI)
- VRNA 61.99
- CAAP 60.70
- Support Level
- VRNA $38.77
- CAAP $19.99
- Resistance Level
- VRNA $43.73
- CAAP $20.79
- Average True Range (ATR)
- VRNA 1.41
- CAAP 0.55
- MACD
- VRNA 0.07
- CAAP 0.09
- Stochastic Oscillator
- VRNA 60.80
- CAAP 80.29
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.